Lisa Shulman is director of autism clinical services at the Children’s Evaluation and Rehabilitation Center at Montefiore Medical Center in New York City.
Lisa Shulman
Director of autism clinical services
Children’s Evaluation and Rehabilitation Center, Montefiore Medical Center
From this contributor
How to help underserved groups gain access to autism care
Place your autism center in the community you serve, remove barriers to care, cast a wide net for autism signs, and do as much as possible in the first visit: These principles can help build a lifelong relationship with the community.
How to help underserved groups gain access to autism care
By
Lisa Shulman
15 January 2019 | 6 min read
Children who ‘recover’ from autism still struggle
Some children with autism lose their diagnosis over time, but still struggle with language, learning and anxiety, says Lisa Shulman.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read